The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484

Science

(2023) · doi:10.1126/science · Cited by 6,063

Untitled work

Colman (2022) · doi:10.1073/pnas · Cited by 4,370

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059

Untitled work

Bloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975

Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy

Ortiz-Islas, E., Montes, P., Rodríguez-Pérez, C. E., Ruiz-Sánchez, E., Sánchez-Barbosa, T., Pichardo-Rojas, D., Zavala‐Tecuapetla, C., Carvajal, K., & Campos‐Peña, V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010128 · Cited by 14

Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases

Reed, A. L., Mitchell, W., Alexandrescu, A. T., & Alder, N. N. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1263420 · Cited by 13

The Hybrid Compounds as Multi-target Ligands for the Treatment of Alzheimer's Disease: Considerations on Donepezil

Gülcan, H. O., & Koşar, M. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666211111153626 · Cited by 12

Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection

Henao‐Restrepo, J., López‐Murillo, C., Valderrama‐Carmona, P., Orozco‐Santa, N., Gomez, J., Gutiérrez‐Vargas, J., Moraga, R., Toledo, J., Littau, J. L., Härtel, S., et al. (2023) · Brain Pathology · doi:10.1111/bpa.13119 · Cited by 11

Protocol Report on the Transcranial Photobiomodulation for Alzheimer’s Disease (TRAP-AD) Study

Iosifescu, D. V., Song, X., Gersten, M. B., Adib, A., Cho, Y., Collins, K. A., Yates, K. F., Puerto, A. M. H., McEachern, K. M., Osorio, R. S., et al. (2023) · Healthcare · doi:10.3390/healthcare11142017 · Cited by 11

β-amyloid’s neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review

O'connell, A., Quinlan, L. R., & Kwakowsky, A. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107436 · Cited by 12

A Map of Transcriptomic Signatures of Different Brain Areas in Alzheimer’s Disease

Ferrari, R. R., Fantini, V., Garofalo, M., Di Gerlando, R., Dragoni, F., Rizzo, B., Spina, E., Rossi, M., Calatozzolo, C., Profka, X., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011117 · Cited by 14

Yi-Zhi-Fang-Dai Formula Exerts a Protective Effect on the Injury of Tight Junction Scaffold Proteins in Vitro and in Vivo by Mediating Autophagy through Regulation of the RAGE/CaMKKβ/AMPK/mTOR Pathway

Chan, Y., Chen, W., Chen, Y., Lv, Z., Wan, W., Li, Y., & Zhang, C. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00379 · Cited by 11

Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors

Gupta, M. L., Kumar, A., Prasun, C., Nair, M. S., Kini, S. G., Yadav, D., & Nain, S. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2106515 · Cited by 11

Proteomics revealed an association between ribosome-associated proteins and amyloid beta deposition in Alzheimer's disease

Feng, L., Wang, G., Song, Q., Feng, X., Su, J., Ji, G., & Li, M. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01330-3 · Cited by 11

The amyloid hypothesis is too good to be true

Kurkinen, M. T. (2017) · Alzheimer s Dementia & Cognitive Neurology · doi:10.15761/adcn.1000106 · Cited by 11

Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease

Hashimoto, M., Ho, G. J., Takamatsu, Y., Wada, R., Sugama, S., Takenouchi, T., Waragai, M., & Masliah, E. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191675 · Cited by 12

The Role of RIN3 Gene in Alzheimer’s Disease Pathogenesis: a Comprehensive Review

Meshref, M. M., Ghaith, H. S., Hammad, M. A., Shalaby, M. M. M., Ayasra, F., Monib, F. A., Attia, M. S., Ebada, M. A., Elsayed, H., Shalash, A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03802-0 · Cited by 12

Alzheimer's disease as an auto-innate immune pathology with potential cell trans-differentiation and enhanced trained immunity in 3xTg-AD mouse model

Saaoud, F., Liu, L., Xu, K., Lu, Y., Shao, Y., Issa, M., Jiang, X., Wang, X., Liu, X., Autieri, M. V., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251329583 · Cited by 13

Biologics as Therapeutical Agents Under Perspective Clinical Studies for Alzheimer’s Disease

Li, H., Shen, X., Zhang, B., & Zhu, Z. (2025) · Molecules · doi:10.3390/molecules30173479 · Cited by 11

2-Hydroxy-Docosahexaenoic Acid Is Converted Into Heneicosapentaenoic Acid via α-Oxidation: Implications for Alzheimer’s Disease Therapy

Parets, S., Irigoyen, Á., Ordinas, M., Cabot, J., Miralles, M., Arbona, L., Péter, M., Balogh, G. E., Fernández‐García, P., Busquets, X., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00164 · Cited by 10

On the propagation of the OH radical produced by Cu-amyloid beta peptide model complexes. Insight from molecular modelling

Arrigoni, F., Rizza, F., Tisi, R., GIOIA, L. D., Zampella, G., & Bertini, L. (2020) · Metallomics · doi:10.1039/d0mt00113a · Cited by 10

Triggering Innate Immune Receptors as New Therapies in Alzheimer’s Disease and Multiple Sclerosis

Piec, P.-A., Pons, V., & Rivest, S. (2021) · Cells · doi:10.3390/cells10082164 · Cited by 10

Recent Advancements in Strategies for Abnormal Protein Clearance in Alzheimer's Disease

Zhuang, J., Gao, J., Yin, Y., Gong, B., Ji, W., Chen, X., Li, P., Cheng, W., Zhao, Y., & He, B. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220214092824 · Cited by 10

[18F]Flotaza for Aβ Plaque Diagnostic Imaging: Evaluation in Postmortem Human Alzheimer’s Disease Brain Hippocampus and PET/CT Imaging in 5xFAD Transgenic Mice

Sandhu, Y. K., Bath, H. S., Shergill, J., Liang, C., Syed, A. U., Ngo, A., Karim, F., Serrano, G. E., Beach, T. G., & Mukherjee, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147890 · Cited by 9

A criterion characterizing accumulated neurotoxicity of Aβ oligomers in Alzheimer's disease

Kuznetsov, A. V. (2025) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2024.0652 · Cited by 10

Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets

Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12

Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future research

Singhaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102821 · Cited by 13

Florbetapir-PET β-amyloid imaging and associated neuropsychological trajectories in survivors of critical illness: A case series

Jackson, J. C., Warrington, H. J., KESSLER, R. M., Kiehl, A. L., & Ely, E. W. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.10.016 · Cited by 9

Micro RNA’s (mirna’s) may help explain expression of multiple genes in Alzheimer’s Frontal Cortex

Bennett, J. P., & Keeney, P. M. (2017) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000178 · Cited by 9

Preferential Intercalation of Human Amyloid-β Peptide into Interbilayer Region of Lipid-Raft Membrane in Macromolecular Crowding Environment

Hirai, M., Ajito, S., Sato, S., Ohta, N., Igarashi, N., & Shimizu, N. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b08006 · Cited by 9

Periphery-confined particulate systems for the management of neurodegenerative diseases and toxicity: Avoiding the blood-brain-barrier challenge

Rabanel, J., Delbreil, P., Banquy, X., Brambilla, D., & Ramassamy, C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.035 · Cited by 10

Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling

Filip, T., Mairinger, S., Neddens, J., Sauberer, M., Flunkert, S., Stanek, J., Wanek, T., Okamura, N., Langer, O., Hutter‐Paier, B., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00916-2 · Cited by 9

Characterization of microtubule-associated protein tau isoforms and Alzheimer’s disease-like pathology in normal sheep (Ovis aries): relevance to their potential as a model of Alzheimer’s disease

Davies, E. S., Morphew, R. M., Cutress, D. J., Morton, A. J., & McBride, S. D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04572-z · Cited by 9

Investigating the amyloid-beta enhancing effect of cGMP in neuro2a cells

Calcagno, E., Caudano, F., Passalacqua, M., Pronzato, M. A., Fedele, E., & Ricciarelli, R. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.001 · Cited by 9

Neuroproteomics Chip-Based Mass Spectrometry and Other Techniques for Alzheimer’s Disease Biomarkers – Update

Pomilio, A. B., Vitale, A. A., & Lazarowski, A. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220413094918 · Cited by 9

Remote Associations Between Tau and Cortical Amyloid-β Are Stage-Dependent

Hojjati, S. H., Chiang, G. C.-Y., Butler, T., de Leon, M. J., Gupta, A. K., Li, Y., Sabuncu, M. R., Feiz, F., Nayak, S., Shteingart, J., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231362 · Cited by 9

Unveiling the Involvement of Herpes Simplex Virus-1 in Alzheimer’s Disease: Possible Mechanisms and Therapeutic Implications

Chauhan, P., Begum, M. Y., Narapureddy, B. R., Gupta, S., Wadhwa, K., Singh, G., Kumawat, R., Sharma, N., Ballal, S., Jha, S. K., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04535-4 · Cited by 9

Anticholinergic Drugs Interact With Neuroprotective Chaperone L-PGDS and Modulate Cytotoxicity of Aβ Amyloids

Low, K. J. Y., Phillips, M., & Pervushin, K. V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00862 · Cited by 8

Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer’s disease

Angrist, M. H., Yang, A., Kantor, B., & Chiba‐Falek, O. (2020) · Life Sciences Society and Policy · doi:10.1186/s40504-020-00106-2 · Cited by 8

Quo vadis PGRMC? Grand-Scale Biology in Human Health and Disease

Cahill, M. A. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2711318 · Cited by 8

Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer’s Disease

Mori, H., Yoshino, Y., Iga, J., Ochi, S., Funahashi, Y., Yamazaki, K., Kumon, H., Ozaki, Y., & Ueno, S. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230078 · Cited by 8

Role of Neurexins in Alzheimer's Disease

Medina-Samamé, A., Paller, É., Bril, M. R., Archvadze, A., Simões-Abade, M. B. C., Cayuela, P. E., & LeMaoult, C. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0169-23.2023 · Cited by 8

Targeting Neurodegeneration: The Emerging Role of Hybrid Drugs

Deb, D., Dhanawat, M., Bhushan, B., Pachuau, L., & Das, N. (2025) · Current Drug Targets · doi:10.2174/0113894501365588250131073304 · Cited by 7

Current amyloid inhibitors: Therapeutic applications and nanomaterial-based innovations

López-García, P., Tejero-Ojeda, M. M., Vaquero, M. E., & Carrión‐Vázquez, M. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102734 · Cited by 8

A Polyaminobiaryl-Based β-secretase Modulator Alleviates Cognitive Impairments, Amyloid Load, Astrogliosis, and Neuroinflammation in APPSwe/PSEN1ΔE9 Mice Model of Amyloid Pathology

Tautou, M., Descamps, F., Larchanché, P.-E., Buée, L., Bakali, J. E., Melnyk, P., & Sergeant, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065285 · Cited by 7

Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging

Sorond, F. A., Whitehead, S. N., Arai, K., Arnold, D. L., Carmichael, S. T., DeCarli, C. S., Duering, M., Fornage, M., Flores‐Obando, R. E., Graff‐Radford, J., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00141-8 · Cited by 7

Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in rats with humanizing mutations in the Aβ-coding region of App

Pham, H., Yin, T., & D’Adamio, L. (2022) · PLOS ONE · doi:10.1371/journal.pone.0263546 · Cited by 6

[125I]IPPI for Tau Imaging: Binding Studies in Postmortem Human Alzheimer’s Disease Hippocampus-Subiculum and Evaluation of Drug effects

Karim, F., Delaney, B. A., Mondal, R., Liang, C., Serrano, G., Beach, T., & Mukherjee, J. (2025) · Synapse · doi:10.1002/syn.70024 · Cited by 5

Organelle stresses and energetic metabolisms promote endothelial–to–mesenchymal transition and fibrosis via upregulating FOSB and MEOX1 in Alzheimer’s disease

Saaoud, F., Issa, M., Liu, L., Xu, K., Lu, Y., Shao, Y., Han, B., Jiang, X., Liu, X., Gillespie, A., et al. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1605012 · Cited by 7

Systems Pharmacology and Pharmacokinetics Strategy to Decode Bioactive Ingredients and Molecular Mechanisms from Zingiber officinale as Phyto-therapeutics against Neurological Diseases

Gollapalli, P., Gnanasekaran, T. S., Rao, S. J. A., Manjunatha, H., Shetty, P. K., & Kumari, S. (2022) · Current Drug Discovery Technologies · doi:10.2174/1570163819666220825141356 · Cited by 8

Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies

Kordi, R., Andrews, T. J., & Hicar, M. D. (2025) · Virology · doi:10.1016/j.virol.2025.110523 · Cited by 6

Evolution of the Research Literature and the Scientific Community of Alzheimer’s Disease from 1983-2017: A 35-Year Survey

Robert, C., Wilson, C. S., Lipton, R. B., & Arreto, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191281 · Cited by 8

Imaging biomolecules in bilayers supported at electrode surfaces

Pięta, P., Sęk, S., & Lipkowski, J. (2023) · Current Opinion in Electrochemistry · doi:10.1016/j.coelec.2023.101318 · Cited by 6

Nanoparticles for the potential treatment of Alzheimer’s disease: A physiopathological approach

Martínez, N. M. N., Toledo, J. A., & Morales, J. O. (2023) · Nanotechnology Reviews · doi:10.1515/ntrev-2022-0548 · Cited by 8

Sporadic Alzheimer’s Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss

Tsamou, M., Carpi, D., Pistollato, F., & Roggen, E. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215434 · Cited by 6

Neurovascular Uncoupling in Alzheimer’s and Parkinson’s Diseases: Mechanisms and Therapeutic Strategies

Ved, A., Gajjar, T. B., Kakkad, A. D., Ganesan, S., Shankhyan, A., Jayabalan, K., Mishra, S., Jain, B., Arora, V., Gulati, M., et al. (2026) · Brain Sciences · doi:10.3390/brainsci16050434 · Cited by 5

Exploring DPP IV inhibitors for Alzheimer’s disease: Bridging diabetes and neurodegeneration

Pattanaik, S., Prusty, S. K., & Sahu, P. K. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149342 · Cited by 5

Recent Advancements in the Early Diagnosis and Treatment of Alzheimer's Disease

Wu, Y., Fu, L., Li, Q., Gao, X., Zhang, Y., Jin, C., Ding, F., Hong, S. C., Cai, H., & Li, Y. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300181 · Cited by 4

Ayurvedic herbs–derived cognitive enhancers for the management of Alzheimer's disease (AD)

Muralidhara, M., & Rajini, P. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19084-1.00002-8 · Cited by 4

N-Formylation modifies membrane damage associated with PSMα3 interfacial fibrillation

Bonnecaze, L., Jumel, K., Vial, A., Khemtémourian, L., Feuillie, C., Molinari, M., Lecomte, S., & Mathelié‐Guinlet, M. (2024) · Nanoscale Horizons · doi:10.1039/d4nh00088a · Cited by 7

How Single Site Mutations Can Help Understanding Structure Formation of Amyloid β1−40

Schwarze, B., & Huster, D. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202200489 · Cited by 5

Oxidative Stress in Neurodegenerative Diseases

Alami, M., Fülöp, T., Boumezough, K., Khalil, A., Zerif, E., & Berrougui, H. (2024) · Springer eBooks · doi:10.1007/978-3-031-69962-7_4 · Cited by 6

Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer’s Disease Mice

Watson, Y., Nelson, B., Kluesner, J. H., Tanzy, C., Ramesh, S., Patel, Z., Kluesner, K. H., Singh, A., Murthy, V., & Mitchell, C. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210492 · Cited by 5

Immunosenescence and Alzheimer’s Disease

Fülöp, T., Larbi, A., Khalil, A., Plotka, A., Laurent, B., Ramassamy, C., Bosco, N., Hirokawa, K., Frost, E. H., & Witkowski, J. M. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_9 · Cited by 4

Neuroprotective Effect of Artemisinin in an Animal Model of Alzheimer’s Disease

Tiratsuyan, S., Hambardzumyan, Y., Poghosyan, M., Danielyan, M., & Hovhannisyan, A. A. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673312842241003111836 · Cited by 4

Exploring LRP-1 in the liver-brain axis: implications for Alzheimer’s disease

Sharma, V. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10980-8 · Cited by 4

A New Bistable Switch Model of Alzheimer’s Disease Pathogenesis

Burlando, B., Losacco, S., Villa, V., Fedele, E., & Ricciarelli, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137061 · Cited by 4

Dementia and cognitive decline

Huq, A. J., Eratne, D., & Velakoulis, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99417-0.00006-9 · Cited by 4

Current status of fluid biomarkers for early Alzheimer's disease and FDA regulation implications

Jamerlan, A., An, S. S. A., & Hulme, J. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123325 · Cited by 3

Combined Preventive and Preconditioning Treatments for the Comorbidity of Alzheimer’s Disease and Ischemic Stroke in a GluN3A Knockout Mouse and a 5xFAD Mouse

Yu, S. P., Gu, X., Jiang, M. Q., Sastry, A., Wu, L., Li, Y., & Wei, L. (2025) · Cells · doi:10.3390/cells14231871 · Cited by 3

Chaperone Activity and Protective Effect against Aβ-Induced Cytotoxicity of Artocarpus camansi Blanco and Amaranthus dubius Mart. ex Thell Seed Protein Extracts

Sanchez-Rodriguez, D., Gonzalez-Figueroa, I., & Alvarez-Berríos, M. P. (2023) · Pharmaceuticals · doi:10.3390/ph16060820 · Cited by 6

Molecular dynamics simulations to explore the binding mode between the amyloid-β protein precursor (APP) and adaptor protein Mint2

Wang, M., & Liu, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-58584-9 · Cited by 3

Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration

Festoff, B. W., Sajja, R. K., & Cucullo, L. (2017) · BioMed Research International · doi:10.1155/2017/1549194 · Cited by 3

Accelerated Molecular Dynamics to Explore the Binding of Transition Metals to Amyloid-β

Kennedy-Britten, O. D., Alshammari, N., & Platts, J. A. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00466 · Cited by 3

Nanotechnology-Based Point-of-Care Diagnostics and Therapeutics for Neurological Disorders

Banik, D., & Bhattacharjee, R. R. (2023) · Smart nanomaterials technology · doi:10.1007/978-981-99-5787-3_12 · Cited by 3

Herbal medicinal plants for the treatment of memory impairment: A futuristic approach for neurological Studies

Kaur, A., Alam, A., Mahmood, T., & Ahsan, F. (2023) · Annals of Phytomedicine An International Journal · doi:10.54085/ap.2023.12.2.5 · Cited by 4

Commercial and Instant Coffees Effectively Lower Aβ1-40 and Aβ1-42 in N2a/APPswe Cells

Zhang, L., Cao, J. A., Yang, H., Pham, P., Khan, U., Brown, B., Wang, Y., Zieneldien, T., & Cao, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.850523 · Cited by 3

Medicinal plants effective against alzheimer’s disease: An update

Khanam, S., & Vayaravel, C. A. (2021) · IP International Journal of Comprehensive and Advanced Pharmacology · doi:10.18231/j.ijcaap.2021.004 · Cited by 3

Nanoparticles in the Treatment of Alzheimer’s Disease with Magnetic Resonance

Zhang, Y., Mao, W., Feng, M., Zhu, N., Yi, W., Fu, H., Guan, H., Nie, T., Zhu, M., & Li, Y. (2021) · Science of Advanced Materials · doi:10.1166/sam.2021.4041 · Cited by 3

Predicting neurodegenerative disease using pre-pathology gut microbiota composition: a longitudinal study in mice modeling Alzheimer’s disease pathologiesPreprint

Borsom, E. M., Conn, K. A., Keefe, C. R., Herman, C., Orsini, G. M., Hirsch, A. H., Avila, M. P., Testo, G., Jaramillo, S. A., Bolyen, E. K., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1538737/v1 · Cited by 3

Mechanistic Insights into the Neuroprotective Potential of Aegle marmelos (L.) Correa Fruits against Aβ-Induced Cell Toxicity in Human Neuroblastoma SH-SY5Y Cells

Adnan, M., Siddiqui, A. J., Bardakçi, F., Surti, M., Badraoui, R., & Patel, M. B. (2025) · Pharmaceuticals · doi:10.3390/ph18040489 · Cited by 2

PolyGR-containing aggregates link with pathology and clinical features of Alzheimer’s disease

Phuong, H. T., Tomas, R. F., Akmese, C., Mijares, A. M. P., Gerstin, I. M., Guo, S., Bell, L. R., Ellwood, R., Yegorova, S., Ng, S. K., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02954-8 · Cited by 2

Tetramethylpyrazine nitrone: a multifaceted neuroprotective agent in neurodegenerative disorders

Bahbah, E. I. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2598227 · Cited by 2

Dysfunction of the CD38-Miro1 Axis Disrupts Astrocyte-neuron Mitochondrial Transfer in Alzheimer’s Disease: Mechanisms and Therapeutic Restoration

Abdelaziz, A. M., Shokr, M. M., Fathy, M. K., & Fawzy, M. N. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02531-y · Cited by 2

Alzheimer Hastalığı’nda In Vivo ve In Vitro Modeller

Aru, B., DEVELİOĞLU, A., Gürel, G., & Demirel, G. Y. (2023) · Türkiye Sağlık Enstitüleri Başkanlığı Dergisi · doi:10.54537/tusebdergisi.1213712 · Cited by 3

Metabolomic of neurodegenerative disorder: Alzheimer’s disease

Ch, R., & Rathor, P. (2024) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2023.09.011 · Cited by 2

The spatial distribution of coupling between tau and neurodegeneration in amyloid-β positive mild cognitive impairment

Robinson, B., Bhamidi, S., & Dayan, E. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.01.014 · Cited by 3

ALZHEIMER HASTALIĞI, RİSK FAKTÖRLERİ VE TEDAVİ

Yıldırım, N., & Eke, B. C. (2024) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1441827 · Cited by 4

The Framework for an Integrative Theory of Alzheimer’s Disease

Zaretsky, D. V., & Zaretskaia, M. V. (2025) · Current Alzheimer Research · doi:10.2174/0115672050381553250425062803 · Cited by 2

Dementias Caused by Persistent Pathogens and the Protective Role of HLA Against them

James, L. M., & Georgopoulos, A. P. (2020) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2019/1.1260 · Cited by 2

Pharmacotherapy for Alzheimer’s disease: what’s new on the horizon?

Khoury, R., Gallop, A., Roberts, K., Grysman, N., Lu, J., & Grossberg, G. T. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2097868 · Cited by 2

Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease

Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00001-7 · Cited by 2

Sex Bias in Preclinical Studies: The Case of Gut Microbiota on Alzheimer’s Disease

Vinardell, M. P. (2021) · Archives in Neurology & Neuroscience · doi:10.33552/ann.2021.11.000752 · Cited by 2

A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s diseasePreprint

Boeddrich, A., Haenig, C., Neuendorf, N., Blanc, E., Ivanov, A., Kirchner, M., Schleumann, P., Bayraktaroğlu, I., Richter, M., Molenda, C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.16.523715 · Cited by 2

Proteomics As A Valid Tool In Biomarker Discovery For Alzheimer's DiseasePreprint

Magnelli, V. (2024) · Preprints.org · doi:10.20944/preprints202401.1595.v1 · Cited by 1

Editorial: Targeting neuron-non-neuronal interactions at the neurovascular unit in stroke and neurodegenerative disease models

Li, C., Liu, Y., Liu, J., & Xu, X. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1353281 · Cited by 2

Neuroprotective effects of hyperbaric oxygen therapy in combination with Schwann cell transplantation in hippocampal fimbria transected rats

Sun, J., Zou, Y., Xiu, G., Lin, B., & Liu, S. (2018) · Ibrain · doi:10.1002/j.2769-2795.2018.tb00026.x · Cited by 1

Benzoquinone Derivatives with Neuroprotective Activities from Lysimachia vulgaris L.

Park, C.-W., Lee, J.-H., Pel, P., Lee, S., & Chin, Y. (2024) · Natural Product Sciences · doi:10.20307/nps.2024.30.1.1 · Cited by 1

Vesicular Transport and Amyloids: The Growing Relationship

Upadhyay, A. (2024) · Biologics · doi:10.3390/biologics4040023 · Cited by 1

A Network-Based Study of the Dynamics of Aβ and τ Proteins in Alzheimer’s Disease

Bianchi, S., Landi, G., Marella, C., Tesi, M. C., Testa, C. M., & Initiative, A. D. N. (2024) · Mathematical and Computational Applications · doi:10.3390/mca29060113 · Cited by 2

Isorhapontigenin, a potential anti-AD natural product targeting multiple pathways, discovered via network proximity and gene enrichment analyses

Guo, P., Guo, P., Zhao, J., Zhang, B., Wang, C., Bai, Y., & Liu, A. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100853 · Cited by 1

The Role of Thionine on Amyloid Precursor Protein Processing in N2a-APPSwe Cells

Önder, S., Biberoğlu, K., & Tacal, Ö. (2025) · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi · doi:10.47572/muskutd.1698250 · Cited by 1

Exploring cannabinoid modulation on autophagy mechanisms in Alzheimer’s disease: a review

Ntsapi, C., Weyers, M., Chinheya, R. M., Jim, T., & Matsabisa, M. G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1748368 · Cited by 2

Emerging pathological mechanisms of Alzheimer’s disease pathogenesis: from neuroimmune interactions to intercellular communication

Wang, R., Feng, Y., Zhou, Z., Jiang, J., Zhang, R., Zou, W., Yang, H., Lv, W., & Shen, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1748418 · Cited by 2

Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis

Fedele, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914499 · Cited by 102

The Amyloid Cascade Hypothesis Has to Deliver, Finally

Behl, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-31570-1_15

Alzheimer's disease and the amyloid cascade hypothesis: ten years on

Sommer, B. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00126-6 · Cited by 98

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188

Alzheimer's disease: The amyloid hypothesis on trial

Harrison, J. R., & Owen, M. J. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.167569 · Cited by 98